PharmaTher Holdings Ltd. (PHRM.CN)
CAD 0.18
(0.0%)
CAD 0.18
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.04 Million CAD | -120.53% |
| 2022 | -3.95 Million CAD | 65.21% |
| 2021 | -3.95 Million CAD | 53.45% |
| 2020 | -2.42 Million CAD | -35679.0% |
| 2019 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -370.85 Thousand CAD | 14.79% |
| 2023 Q2 | -735.07 Thousand CAD | 45.14% |
| 2023 Q4 | -386.27 Thousand CAD | 13.84% |
| 2023 Q3 | -448.32 Thousand CAD | 39.01% |
| 2023 Q1 | -1.34 Million CAD | -123.4% |
| 2022 Q3 | -828.55 Thousand CAD | -217.86% |
| 2022 FY | - CAD | 65.21% |
| 2022 Q4 | -599.82 Thousand CAD | 27.61% |
| 2022 Q2 | 702.99 Thousand CAD | 207.38% |
| 2022 Q1 | -654.64 Thousand CAD | 76.31% |
| 2021 Q4 | -2.76 Million CAD | -426.34% |
| 2021 FY | - CAD | 53.45% |
| 2021 Q3 | 846.69 Thousand CAD | 143.72% |
| 2021 Q2 | -1.93 Million CAD | -1597.11% |
| 2021 Q1 | -114.11 Thousand CAD | 74.25% |
| 2020 Q2 | -1.16 Million CAD | -242.44% |
| 2020 Q3 | -6.76 Million CAD | -480.28% |
| 2020 Q1 | -340.61 Thousand CAD | 0.0% |
| 2020 FY | - CAD | -35679.0% |
| 2020 Q4 | -443.15 Thousand CAD | 93.45% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | 38.906% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 62.594% |
| BetterLife Pharma Inc. | -3.19 Million CAD | 4.64% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 60.41% |
| ChitogenX Inc. | -2.69 Million CAD | -12.968% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | -0.616% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 75.991% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 21849.225% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | 41.2% |
| Glow Lifetech Corp. | -1.26 Million CAD | -140.956% |
| Lexston Life Sciences Corp. | -648.32 Thousand CAD | -369.421% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | -328.532% |
| Doseology Sciences Inc. | -319.47 Thousand CAD | -852.607% |
| MYND Life Sciences Inc. | -1.82 Million CAD | -66.742% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -153.129% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | -218.648% |
| Telescope Innovations Corp. | -5.49 Million CAD | 44.57% |